Geron (GERN)
(Delayed Data from NSDQ)
$3.80 USD
-0.08 (-2.06%)
Updated May 10, 2024 04:00 PM ET
After-Market: $3.80 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Geron Corporation [GERN]
Reports for Purchase
Showing records 161 - 180 ( 236 total )
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
We are placing Geron Corp. under review due to the departure of the covering analyst
Provider: RODMAN & RENSHAW, CO.
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
1Q12 UPDATE - BUILDING AN ONCOLOGY FRANCHISE - KEY DRIVERS EXPECTED IN 4Q12
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
1Q12 UPDATE - BUILDING AN ONCOLOGY FRANCHISE - KEY DRIVERS EXPECTED IN 4Q12
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Highlights From Meeting with Management - Several Key Data Drivers Expected in 2012
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Highlights From Meeting with Management - Several Key Data Drivers Expected in 2012
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Biotechnology -SUMMARIES FROM PRESENTATIONS OF COMPANIES UNDER COVERAGE OR REVIEW
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Biotechnology -SUMMARIES FROM PRESENTATIONS OF COMPANIES UNDER COVERAGE OR REVIEW
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
4Q11 UPDATE - PIPELINE REVAMPED, STREAMLINED AND ONCOLOGY-FOCUSED
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
4Q11 UPDATE - PIPELINE REVAMPED, STREAMLINED AND ONCOLOGY-FOCUSED
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
2011 Results; Playing the Waiting Game for Year End Data
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
New Management - New Focus - New Execution - Imetelstat on Track for New Data
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R